BriaCell Therapeutics Corp financial statements
BriaCell Therapeutics Corp's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Net income | −USD 34.9M | 10-K |
| Cash and equivalents | USD 9.85M | 10-K |
BriaCell Therapeutics Corp financials on 6ix · BriaCell Therapeutics Corp on 6ix